Market Reports /
by Peter Milios -
A year ago
21 Jun 2023 - On Wednesday, the S&P/ASX 200 experienced its first drop in seven days, declining by 0.6 per cent. This was primarily driven by a 1.3 per cent decrease in the energy …
Market Reports /
by Peter Milios -
A year ago
21 Jun 2023 - Office and industrial property group, Dexus (ASX:DXS), has reduced the book value of its office and industrial properties by approximately $1 billion (6% reduction) d…
Company Presentations /
by Finance News Network -
A year ago
27 Feb 2023 - Robert Proulx - President and CEO - Imagion Biosystems is developing new ways -- based on its proprietary nanoparticle technology -- to allow doctors to identify the …
Market Reports /
by Peter Milios -
A year ago
06 Feb 2023 - All sectors besides Energy and Materials are trading lower today, after the US sectors fell on Friday due to a strong jobs report, which caused some investors to worr…
Market Reports /
by Peter Milios -
A year ago
08 Dec 2022 - Goldman Sachs have extended their bearish views on lithium, believing that the prices are expected to decline from the second half of 2023.
Market Reports /
by Lauren Hayes -
A year ago
08 Dec 2022 - The Australian market is still unnerved over concerns about a possible US recession. Energy is weighing down the benchmark over fears demand for oil will be impacted …
Company News /
by Jessica Amir -
6 years ago
10 Oct 2017 - Imagion Biosystems (ASX:IBX) has contracted a nanoparticle manufacturer to produce its first formulations for clinical breast cancer studies.